The trading week after the 4th of July typically sets the stage for some real summer sizzle on Wall Street. And next week is shaping up to be a doozy for investors, with a diverse slate of 8 companies across industries readying their latest earnings ammunition.
From a miracle diabetes pill maker to the perpetual cash machine that is WD-40, these eagerly anticipated reports have serious potential to spark rallies or sell-offs. Buckle up and get these tickers on your radar now!
Oramed Pharmaceuticals (ORMP) - The $105 million biotech is gunning for FDA approval of its revolutionary oral insulin capsule that could revolutionize diabetes treatment. Analysts see a profit in the cards when Oramed prints its fiscal Q4 numbers on July 10th.
Nurix Therapeutics (NRIX) - This $1.2 billion cancer biotech aims to continue validating its innovative protein platform when Q4 results hit the wires. The Street sees a loss but is overwhelmingly bullish long-term with 27% upside baked into the stock.
AngioDynamics (ANGO) - The $227 million medical devices maker is expected to bleed red ink to the tune of -$0.14 per share for fiscal Q4 on July 10th. But with ANGO stock down 50% from highs and massive 160%+ projected upside, any positive surprise could juice the rally.
WD-40 Company (WDFC) - Few consumer staples are as consistent as the famed lubricants titan behind its namesake WD-40 brand. Slated for July 10th, the company is forecast to squirt out $1.11 in fiscal Q3 EPS as profits and cash keep flowing freely.
AZZ Inc. (AZZ) - The electrical equipment and industrial components play should ring the register with $0.70 in EPS for its fiscal Q1 release. With the Zacks rank in elite territory, this $2.2 billion stock may well beat elevated expectations.
Loop Industries (LOOP) - This $100 million circular plastics upstart is set to take another step towards profitability with a projected -$0.10 per share loss for Q4 next week. High short interest makes LOOP a definite watch for any unexpected upside catalysts.
E2open Parent Holdings (ETWO) - The $1.4 billion supply chain software firm likely grew June quarter profits 10% to $0.044 per share, sustaining momentum for the newly-public cloud play. Analysts see over 5% near-term upside here.
.png) |
6 Things Not to Do When Selecting a Financial Advisor Working with a financial advisor can be a great first step to helping make sure you're on track to reach your retirement goals. But choosing the wrong one could wreak havoc. Be aware of these 6 mistakes when choosing a financial advisor, so you can work to potentially avoid years of stress. See the list. |
PriceSmart (PSMT) - The $2.4 billion operator of warehouse club stores across Latin America and the Caribbean should match last year's $1.24 in EPS for fiscal Q3 ended May. Robust traffic and pricing power could set up an over-earnings celebration.
Make no mistake - those upside and downside surprises lurking in this eclectic batch of earnings reports have serious potential to spark fireworks. Stocks that deliver could ignite rallies while duds get swiftly punished by an unforgiving market.
Analysts have sized up their targets and crunched estimates, but there's nothing like getting profits straight from the horse's mouth. For these 8 companies at least, that's precisely what traders will be feasting on over the next week as summertime sizzle hits Wall Street's grill.
Every season produces its share of winners and losers in the earnings spotlight. But by keeping a trained eye on this particular set of high-impact reports, you'll ensure your portfolio is properly positioned - no matter which way the fireworks ultimately fly.
